Zhengye Biotechnology (ZYBT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.40, -6.67% vs the prior close of $1.50.
- Volume 81.29K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ZYBT slides 6.7% to $1.40. Closed at $1.40, -6.67% vs the prior close of $1.50. Day range $1.38β$1.57, opened at $1.50.
ZYBT daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ZYBT slides 6.7% to $1.40
- Closed at $1.40, -6.67% vs the prior close of $1.50. Day range $1.38β$1.57, opened at $1.50.
- Volume was 81.29K shares, 0.1x its 50-day average of 1.11M β lighter than usual.
- Price is -8.1% vs its 50-day average ($1.52) and +22.7% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 11% of that range, 82.5% below the 52-week high.
Oct 15, 2026 β ZYBT dips 2.0% to $1.50
- Closed at $1.50, -1.96% vs the prior close of $1.53. Day range $1.48β$1.66, opened at $1.50.
- Volume was 67.70K shares, 0.0x its 50-day average of 2.54M β lighter than usual.
- Price is -2.4% vs its 50-day average ($1.54) and +31.6% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 12% of that range, 81.3% below the 52-week high.
Oct 14, 2026 β ZYBT jumps 3.4% to $1.53
- Closed at $1.53, +3.38% vs the prior close of $1.48. Day range $1.44β$1.72, opened at $1.45.
- Volume was 255.30K shares, 0.1x its 50-day average of 2.54M β lighter than usual.
- Price is -1.6% vs its 50-day average ($1.55) and +34.4% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 12% of that range, 80.9% below the 52-week high.
Oct 13, 2026 β ZYBT slides 12.4% to $1.48
- Closed at $1.48, -12.43% vs the prior close of $1.69. Day range $1.43β$1.75, opened at $1.43.
- Volume was 425.30K shares, 0.2x its 50-day average of 2.53M β lighter than usual.
- Price is -4.5% vs its 50-day average ($1.55) and +30.0% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 12% of that range, 81.5% below the 52-week high.
Oct 12, 2026 β ZYBT dips 2.3% to $1.69
- Closed at $1.69, -2.31% vs the prior close of $1.73. Day range $1.38β$1.85, opened at $1.82.
- Volume was 2.93M shares, 1.2x its 50-day average of 2.48M.
- Price is +9.3% vs its 50-day average ($1.55) and +48.4% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 15% of that range, 78.9% below the 52-week high.
Oct 9, 2026 β ZYBT jumps 50.4% to $1.73, a 1-month high on 16.3x normal volume
- Closed at $1.73, +50.43% vs the prior close of $1.15. Day range $1.12β$2.89, opened at $1.19.
- Volume was 30.60M shares, 16.3x its 50-day average of 1.87M β unusually heavy trading.
- Price is +12.4% vs its 50-day average ($1.54) and +51.8% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 15% of that range, 78.4% below the 52-week high.
Oct 8, 2026 β ZYBT dips 0.9% to $1.15
- Closed at $1.15, -0.86% vs the prior close of $1.16. Day range $1.12β$1.17, opened at $1.13.
- Volume was 10.30K shares, 0.0x its 50-day average of 1.88M β lighter than usual.
- Price is -24.9% vs its 50-day average ($1.53) and +0.9% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 7% of that range, 85.6% below the 52-week high.
Oct 7, 2026 β ZYBT jumps 4.5% to $1.16
- Closed at $1.16, +4.50% vs the prior close of $1.11. Day range $1.09β$1.18, opened at $1.09.
- Volume was 31.70K shares, 0.0x its 50-day average of 1.88M β lighter than usual.
- Price is -24.4% vs its 50-day average ($1.53) and +1.4% vs its 200-day average ($1.14).
- 52-week range $0.62β$8.01; today's close sits at 7% of that range, 85.5% below the 52-week high.
Oct 6, 2026 β ZYBT slides 6.7% to $1.11, a 1-month low, 3 down days in a row
- Closed at $1.11, -6.72% vs the prior close of $1.19. Day range $1.11β$1.20, opened at $1.11.
- Volume was 44.40K shares, 0.0x its 50-day average of 1.90M β lighter than usual.
- Price is -27.8% vs its 50-day average ($1.54) and -3.2% vs its 200-day average ($1.15).
- 52-week range $0.62β$8.01; today's close sits at 7% of that range, 86.1% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 β ZYBT slides 4.0% to $1.19, a 1-month low
- Closed at $1.19, -4.03% vs the prior close of $1.24. Day range $1.18β$1.27, opened at $1.23.
- Volume was 14.60K shares, 0.0x its 50-day average of 1.93M β lighter than usual.
- Price is -23.0% vs its 50-day average ($1.55) and +3.5% vs its 200-day average ($1.15).
- 52-week range $0.62β$8.01; today's close sits at 8% of that range, 85.1% below the 52-week high.
Oct 2, 2026 β ZYBT dips 1.6% to $1.24
- Closed at $1.24, -1.59% vs the prior close of $1.26. Day range $1.20β$1.26, opened at $1.26.
- Volume was 15.90K shares, 0.0x its 50-day average of 2.24M β lighter than usual.
- Price is -20.3% vs its 50-day average ($1.56) and +7.5% vs its 200-day average ($1.15).
- 52-week range $0.62β$8.01; today's close sits at 8% of that range, 84.5% below the 52-week high.
ZYBT latest news & SEC filings
Every SEC filing by or about ZYBT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 6, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 21, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 25, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Jun 25, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Jun 25, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Jun 25, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Jun 25, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Things to know before you trade ZYBT
- How much it moves: over the last 20 sessions the average daily move was 6.33% (largest 50.4%). That is a volatile stock.
- Liquidity: about 1.73M shares (β$2.42M) trade per day on average.
- 52-week position: $1.40 vs a range of $0.62β$8.01 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Aug 6, 2026; 6-K Jul 21, 2026; 6-K Jun 4, 2026.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
ZYBT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.50 | 1.57 | 1.38 | 1.40 | 81.29K |
| Oct 15, 2026 | 1.50 | 1.66 | 1.48 | 1.50 | 67.70K |
| Oct 14, 2026 | 1.45 | 1.72 | 1.44 | 1.53 | 255.30K |
| Oct 13, 2026 | 1.43 | 1.75 | 1.43 | 1.48 | 425.30K |
| Oct 12, 2026 | 1.82 | 1.85 | 1.38 | 1.69 | 2.93M |
| Oct 9, 2026 | 1.19 | 2.89 | 1.12 | 1.73 | 30.60M |
| Oct 8, 2026 | 1.13 | 1.17 | 1.12 | 1.15 | 10.30K |
| Oct 7, 2026 | 1.09 | 1.18 | 1.09 | 1.16 | 31.70K |
| Oct 6, 2026 | 1.11 | 1.20 | 1.11 | 1.11 | 44.40K |
| Oct 5, 2026 | 1.23 | 1.27 | 1.18 | 1.19 | 14.60K |
| Oct 2, 2026 | 1.26 | 1.26 | 1.20 | 1.24 | 15.90K |
| Oct 1, 2026 | 1.20 | 1.29 | 1.20 | 1.26 | 13.80K |
| Sep 30, 2026 | 1.26 | 1.26 | 1.20 | 1.20 | 13.80K |
| Sep 29, 2026 | 1.29 | 1.37 | 1.24 | 1.24 | 20.50K |
| Sep 28, 2026 | 1.31 | 1.37 | 1.26 | 1.30 | 10.00K |
| Sep 25, 2026 | 1.29 | 1.35 | 1.26 | 1.30 | 19.30K |
| Sep 24, 2026 | 1.30 | 1.37 | 1.30 | 1.31 | 8.80K |
| Sep 23, 2026 | 1.28 | 1.38 | 1.28 | 1.37 | 28.30K |
| Sep 22, 2026 | 1.35 | 1.35 | 1.26 | 1.28 | 24.40K |
| Sep 21, 2026 | 1.34 | 1.38 | 1.34 | 1.35 | 17.60K |
About Zhengye Biotechnology
Zhengye Biotechnology (ZYBT) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in JILIN. State of incorporation: China. Fiscal year ends β. SEC CIK 1975641.
ZYBT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Zhenfa Han | Director | Jun 25, 2026 |
| Qiyi Hu | Director | Apr 24, 2026 |
| Ping (Piji) Jiang | Director | Jun 25, 2026 |
| Guohan (Nmn) Li | Director | Apr 24, 2026 |
| Wenhua Sun | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yuhong (Nmn) Cheng | Vice General Manager | Jun 25, 2026 |
| Aiden Han | Co-Chief Executive Officer | Mar 18, 2026 |
| Wei Lian | Vice General Manager | Mar 18, 2026 |
| Zhongyao Liu | Chief Operating Officer | Mar 18, 2026 |
| Songlin Song | Co-Chief Executive Officer | Jun 25, 2026 |
| Ping (Nmn) Wang | Chief Financial Officer | Jun 25, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ZYBT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
ZYBT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ZYBT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.